Parmax Pharma Ltd Q3FY21 PAT up at Rs. 1.53 crore
Posted On:
Parmax Pharma Ltd has reported financial results for the period ended December 31, 2020.
Financial Results (Q3 FY20-21) - QoQ Comparison
The company has reported total income of Rs.10.47 crores during the period ended December 31, 2020 as compared to Rs.6.11 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.1.53 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.0.51 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.4.11 for the period ended December 31, 2020 as compared to Rs.1.38 for the period ended September 30, 2020.